Filing Details
- Accession Number:
- 0001654954-18-003882
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-12 16:05:33
- Reporting Period:
- 2018-04-10
- Accepted Time:
- 2018-04-12 16:05:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1378624 | Cellular Biomedicine Group Inc. | CBMG | Biological Products, (No Disgnostic Substances) (2836) | 861032927 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1569874 | Tao Wen Liu | 19925 Stevens Creek Blvd., Suite 100 Cupertino CA 95014 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-04-10 | 10,400 | $15.53 | 223,476 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-04-10 | 10,400 | $20.10 | 213,076 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-04-11 | 12,044 | $15.53 | 225,120 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-04-11 | 12,044 | $20.08 | 213,076 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qlfd. Stock Option(right to buy)(2014 Plan-Grant 14-142) | Disposition | 2018-04-10 | 10,400 | $0.00 | 10,400 | $15.53 |
| Common Stock | Non-Qlfd. Stock Option(right to buy)(2014 Plan-Grant 14-142) | Disposition | 2018-04-11 | 12,044 | $0.00 | 12,044 | $15.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,044 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct |
Footnotes
- The transactions reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transactions.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.05 to $20.20, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.40, inclusive.
- This option vested over a period of three years according to the following schedule: 1/3 on December 31, 2015 and 1/3 on each anniversary thereafter. The expiration date of such option is May 6, 2017 or 3 months after the reporting person ceases serving on the board of directors of the registrant, whichever is later.
Billionaire Hedge Funds
